A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study,,

OBJECTIVE: To define the maximum tolerated dose (MTD) and assess the feasibility of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in women with newly diagnosed Stages II–IV ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS: Patients received escalat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gould, Natalie, Sill, Michael W., Mannel, Robert S., Thaker, P.H., DiSilvestro, Paul, Waggoner, Steve, Yamada, S. Diane, Armstrong, Deborah K., Wenzel, Lari, Huang, Helen, Fracasso, Paula M., Walker, Joan L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670678/
https://ncbi.nlm.nih.gov/pubmed/22155262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.12.417
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados